Subscribe To
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position expected to fund operations into second quarter of 2025 Two Phase 1 clinical trials of lead program, TIDAL-01, in several solid tumor Indications ongoing SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics […] The post Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update appeared first on...
Read More
Posted: Sep 1 2023, 21:57
Author Name: forextv
Views: 111692